Cargando…
Which Vaccine? The Cost of Religious Freedom in Vaccination Policy
We discuss whether and under what conditions people should be allowed to choose which COVID-19 vaccine to receive on the basis of personal ethical views. The problem arises primarily with regard to some religious groups’ concerns about the connection between certain COVID-19 vaccines and abortion. V...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696246/ https://www.ncbi.nlm.nih.gov/pubmed/34940937 http://dx.doi.org/10.1007/s11673-021-10148-6 |
_version_ | 1784619765322481664 |
---|---|
author | Giubilini, Alberto Savulescu, Julian Wilkinson, Dominic |
author_facet | Giubilini, Alberto Savulescu, Julian Wilkinson, Dominic |
author_sort | Giubilini, Alberto |
collection | PubMed |
description | We discuss whether and under what conditions people should be allowed to choose which COVID-19 vaccine to receive on the basis of personal ethical views. The problem arises primarily with regard to some religious groups’ concerns about the connection between certain COVID-19 vaccines and abortion. Vaccines currently approved in Western countries make use of foetal cell lines obtained from aborted foetuses either at the testing stage (Pfizer/BioNTech and Moderna vaccines) or at the development stage (Oxford/AstraZeneca vaccine). The Catholic Church’s position is that, if there are alternatives, Catholic people have a moral obligation to request the vaccine whose link with abortion is more remote, which at present means that they should refuse the Oxford/AstraZeneca vaccine. We argue that any consideration regarding free choice of the vaccine should apply to religious and non-religious claims alike, in order to avoid religion-based discrimination. However, we also argue that, in a context of limited availability, considering the significant differences in costs and effectiveness profile of the vaccines available, people should only be allowed to choose the preferred vaccine if: 1) this does not risk compromising vaccination strategies; and 2) they internalize any additional cost that their choice might entail. The State should only subsidize the vaccine that is more cost-effective for any demographic group from the point of view of public health strategies. |
format | Online Article Text |
id | pubmed-8696246 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-86962462021-12-23 Which Vaccine? The Cost of Religious Freedom in Vaccination Policy Giubilini, Alberto Savulescu, Julian Wilkinson, Dominic J Bioeth Inq Original Research We discuss whether and under what conditions people should be allowed to choose which COVID-19 vaccine to receive on the basis of personal ethical views. The problem arises primarily with regard to some religious groups’ concerns about the connection between certain COVID-19 vaccines and abortion. Vaccines currently approved in Western countries make use of foetal cell lines obtained from aborted foetuses either at the testing stage (Pfizer/BioNTech and Moderna vaccines) or at the development stage (Oxford/AstraZeneca vaccine). The Catholic Church’s position is that, if there are alternatives, Catholic people have a moral obligation to request the vaccine whose link with abortion is more remote, which at present means that they should refuse the Oxford/AstraZeneca vaccine. We argue that any consideration regarding free choice of the vaccine should apply to religious and non-religious claims alike, in order to avoid religion-based discrimination. However, we also argue that, in a context of limited availability, considering the significant differences in costs and effectiveness profile of the vaccines available, people should only be allowed to choose the preferred vaccine if: 1) this does not risk compromising vaccination strategies; and 2) they internalize any additional cost that their choice might entail. The State should only subsidize the vaccine that is more cost-effective for any demographic group from the point of view of public health strategies. Springer Singapore 2021-12-23 2021 /pmc/articles/PMC8696246/ /pubmed/34940937 http://dx.doi.org/10.1007/s11673-021-10148-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Research Giubilini, Alberto Savulescu, Julian Wilkinson, Dominic Which Vaccine? The Cost of Religious Freedom in Vaccination Policy |
title | Which Vaccine? The Cost of Religious Freedom in Vaccination Policy |
title_full | Which Vaccine? The Cost of Religious Freedom in Vaccination Policy |
title_fullStr | Which Vaccine? The Cost of Religious Freedom in Vaccination Policy |
title_full_unstemmed | Which Vaccine? The Cost of Religious Freedom in Vaccination Policy |
title_short | Which Vaccine? The Cost of Religious Freedom in Vaccination Policy |
title_sort | which vaccine? the cost of religious freedom in vaccination policy |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696246/ https://www.ncbi.nlm.nih.gov/pubmed/34940937 http://dx.doi.org/10.1007/s11673-021-10148-6 |
work_keys_str_mv | AT giubilinialberto whichvaccinethecostofreligiousfreedominvaccinationpolicy AT savulescujulian whichvaccinethecostofreligiousfreedominvaccinationpolicy AT wilkinsondominic whichvaccinethecostofreligiousfreedominvaccinationpolicy |